Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Teva Pharmaceutical Industries Limited American Depositary Shares
(NY:
TEVA
)
16.83
-0.46 (-2.66%)
Official Closing Price
Updated: 7:00 PM EST, Feb 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
14,408,396
Open
17.27
Bid (Size)
16.83 (15)
Ask (Size)
16.91 (3)
Prev. Close
17.29
Today's Range
16.61 - 17.31
52wk Range
11.83 - 22.80
Shares Outstanding
1,110,352,397
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Neurocrine Biosciences Reports Mixed Q4
February 07, 2025
Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while revenue slightly missed estimates.
Via
The Motley Fool
Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now
February 03, 2025
Teva Pharmaceuticals is the world's largest generic drug maker with over 500 generics in its portfolio, but shares sold off on its recent earnings, buying opp?
Via
MarketBeat
Performance
YTD
-20.99%
-20.99%
1 Month
-19.63%
-19.63%
3 Month
-3.11%
-3.11%
6 Month
-1.46%
-1.46%
1 Year
+40.13%
+40.13%
More News
Read More
NVIDIA, Teva Pharmaceutical And UPS Are Among Top Large Cap Losers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio?
February 02, 2025
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Teva Pharmaceutical Indus Options Trading: A Deep Dive into Market Sentiment
January 30, 2025
Via
Benzinga
What Analysts Are Saying About Teva Pharmaceutical Indus Stock
January 30, 2025
Via
Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today
January 27, 2025
Via
Benzinga
Peering Into Teva Pharmaceutical Indus's Recent Short Interest
January 27, 2025
Via
Benzinga
Why Teva Pharmaceutical Stock Is Sinking Today
January 29, 2025
Via
The Motley Fool
Teva Pharmaceutical Industries (TEVA) Q4 2024 Earnings Call Transcript
January 29, 2025
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Crude Oil Down 1.5%; Teva Pharmaceutical Shares Plummet
January 29, 2025
Via
Benzinga
Exposures
Fossil Fuels
Stocks Scatter As Investors Prepare For Fed Remarks
January 29, 2025
Via
Talk Markets
Topics
Economy
Stocks / Equities
Exposures
Interest Rates
Nasdaq Down Over 100 Points; Corning Posts Upbeat Earnings
January 29, 2025
Via
Benzinga
Stocks Tick Down Ahead Of Fed Meeting, Nvidia Jitters Resume, Trump Media Rallies: What's Driving Markets Wednesday?
January 29, 2025
Via
Benzinga
Topics
Economy
Government
Exposures
Interest Rates
Political
Teva Pharmaceutical Posts Lower Revenue. Stock Slips.
January 29, 2025
Via
Investor's Business Daily
Teva Pharmaceutical Stock Falls On Q4 Earnings: What's Going On?
January 29, 2025
Via
Benzinga
Manhattan Associates, LendingClub And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
January 29, 2025
Via
Benzinga
Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth
January 29, 2025
From
Teva Pharmaceutical Industries Ltd
Via
GlobeNewswire
Teva's Duvakitug Set To Shake Up IBD Treatment, Analyst Highlights Competitive Data
January 28, 2025
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2025
Via
Benzinga
Earnings Scheduled For January 29, 2025
January 29, 2025
Via
Benzinga
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
January 27, 2025
From
Alvotech
Via
GlobeNewswire
FDA Warns Of Severe Allergic Reaction Risk With Teva's Multiple Sclerosis Drug
January 23, 2025
Via
Benzinga
Exposures
Product Safety
Promising Signs: TEVA PHARMACEUTICAL-SP ADR Setting the Stage for a Breakout.
January 23, 2025
Via
Chartmill
Teva Challenges Drug Price Law's Impact On Innovation, Generics
January 17, 2025
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
January 17, 2025
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.